Page last updated: 2024-09-03

sk&f 104976 and 5,22-cholestadien-3beta-ol

sk&f 104976 has been researched along with 5,22-cholestadien-3beta-ol in 1 studies

Compound Research Comparison

Studies (sk&f 104976)	Trials (sk&f 104976)	Recent Studies (post-2010) (sk&f 104976)	Studies (5,22-cholestadien-3beta-ol)	Trials (5,22-cholestadien-3beta-ol)	Recent Studies (post-2010) (5,22-cholestadien-3beta-ol)
10	0	1	8	0	1

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Busto, R; Cano, S; Dávalos, A; de la Peña, G; Giera, M; Herrera, E; Lasunción, MA; Sánchez-Wandelmer, J	1

Other Studies

1 other study(ies) available for sk&f 104976 and 5,22-cholestadien-3beta-ol

Article	Year
Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes. Biochimica et biophysica acta, 2009, Volume: 1788, Issue:9 Topics: 3T3-L1 Cells; Animals; Caveolae; Caveolin 1; Cell Membrane; Cholesterol; Dehydrocholesterols; Enzyme Inhibitors; G(M1) Ganglioside; Lanosterol; Membrane Microdomains; Mice; Receptor, Insulin; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; Triparanol	2009

Article

Year

Inhibition of cholesterol biosynthesis disrupts lipid raft/caveolae and affects insulin receptor activation in 3T3-L1 preadipocytes.

Biochimica et biophysica acta, 2009, Volume: 1788, Issue:9

Topics: 3T3-L1 Cells; Animals; Caveolae; Caveolin 1; Cell Membrane; Cholesterol; Dehydrocholesterols; Enzyme Inhibitors; G(M1) Ganglioside; Lanosterol; Membrane Microdomains; Mice; Receptor, Insulin; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride; Triparanol

2009